Cited by 260Lipid metabolism and disordersLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 159 of the 160 references it cites were found in a registry or an index.

Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease

Open access

Rosenson, Robert S., Davidson, Michael H., Hirsh, Benjamin J., Kathiresan, Sekar, Gaudet, Daniel·2014·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2014.09.042

Open this paper in CoChat — free account Open PDF

Abstract

Triglycerides represent 1 component of a heterogeneous pool of triglyceride-rich lipoproteins (TGRLs). The reliance on triglycerides or TGRLs as cardiovascular disease (CVD) risk biomarkers prompted investigations into therapies that lower plasma triglycerides as a means to reduce CVD events. Genetic studies identified TGRL components and pathways involved in their synthesis and metabolism. We advocate that only a subset of genetic mechanisms regulating TGRLs contribute to the risk of CVD events. This "omic" approach recently resulted in new targets for reducing CVD events.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2014.09.042

Cites

159 of 159 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Self-citation
Untitled work
Willer (2013) · doi:10.1038/ng.2797 · Cited by 2,983
Self-citation
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
Self-citation
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731

Flagged first, then by citations

Show all 160 references

1 of the 160 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–259 of 259

Nonlinear relationship between incidence of new-onset stroke and plasma atherosclerotic index in middle-aged and older adults
Wang, Q., Zhao, L., Zuo, T., & Peng, W. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1597616 · Cited by 1
Hypertriglyceridemia (triglyceride-rich lipoproteins and their remnants): role in development of atherosclerotic cardiovascular diseases and control strategy consensus statement of the expert Committee of the Russian Society of Cardiology (RSC), the National Atherosclerosis Society (NAS), and the Russian Society of Cardiovascular Prevention and Rehabilitation (RosOKR)
Bubnova, M. G., Ezhov, M. V., Aronov, D. M., Galyаvich, A. S., Gurevich, V. S., Duplyakov, D. V., Zafiraki, V. K., Karamnova, N. S., Kashtalap, V. V., Konovalov, G. A., et al. (2025) · Cardiosomatics · doi:10.17816/cs688224 · Cited by 1
Nonlinear Association Between Atherogenic Index of Plasma and Unstable Carotid Plaque: A Single-Center Retrospective Study
Huo, G., Tang, Y., & Zhou, D. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12110443 · Cited by 1
Remnant Cholesterol is Associated with Blood Pressure Control in US Adults with Hypertension: NHANES 2007–2018 Analysis
Feng, S., Zou, S., Tang, M., Tian, R., & Xu, Y. (2025) · Vascular Health and Risk Management · doi:10.2147/vhrm.s553282 · Cited by 1
The effects of a body shape index and remnant cholesterol inflammatory index on incident cardiovascular diseases: insights from a nationwide cohort study
Xu, L., Ma, J., Liu, J., Li, Y., & Xu, Y. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02893-7 · Cited by 1
Post-heparin plasma lipase activities in patients with severe hypertriglyceridemia treated with evinacumab
Vitali, C., Banerjee, P., Pordy, R. C., Ehmann, P. J., Rosenson, R. S., & Rader, D. J. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101020 · Cited by 1
Self-citation
Causal statistical association between remnant cholesterol and coronary heart disease: genetic insights into the PSRC1–CELSR2–SORT1 gene cluster
Han, G., Lei, C. L., Shi, Y., Gao, J., Liu, X., Peng, K., Cai, Y., Hoi, P. M., & Yichong, L. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101047 · Cited by 1
Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case–control and meta-analysis study
Yang, G., Lei, M.-M., Yu, C.-L., Liu, X.-X., An, Z., & Song, C.-L. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0110-6 · Cited by 1
How important are triglycerides as risk factors?
D’Addato, S., Palmisano, S., & Borghi, C. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000438 · Cited by 1
Small triumph for fenofibrate therapy in dyslipidaemia
Rosenson, R. S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.11 · Cited by 1
Self-citation
Clinical Assessment of Brachial-Ankle Pulse Wave Velocity and Stiffness Index: Hypertriglyceridemia Effects on Arterial Stiffness
Zhao, A., Chong, Y., Zhong, H., Ma, J., Zhang, H., Luo, Z., Li, G., & Luo, X. (2017) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2017.00008 · Cited by 1
Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis
Kang, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100998 · Cited by 1
Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier
Kwaifa, I. K., Mainasara, A. S., Jidda, M. L., Amin, A. M., Abdullahi, G., Ladan, F., & Danyaro, M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108199 · Cited by 1
Thyroid, Lipids, and Risk of Atherosclerosis
Brenta, G., & Schreier, L. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_19 · Cited by 1
The year 2019 in Atherosclerosis
Binder, C. J., Borén, J., Catapano, A. L., Dallinga‐Thie, G. M., Kronenberg, F., Mallat, Z., Negrini, S., Raggi, P., & von Eckardstein, A. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.03.018 · Cited by 1
Is HbA1c level affected by high triglyceride levels?
Araç, E., & Solmaz, İ. (2020) · Ortadoğu Tıp Dergisi · doi:10.21601/ortadogutipdergisi.715645 · Cited by 1
Global assessment improves risk stratification for major adverse cardiac events across a wide range of triglyceride levels: Insights from the KP REACH study
Wagner, J. R., Fitzpatrick, J. K., Yang, J., Sung, S. H., Allen, A., Philip, S., Granowitz, C. B., Abrahamson, D., Ambrosy, A. P., & Go, A. S. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100319 · Cited by 1
ANGPTL3 Is Involved in the Post-prandial Response in Triglyceride-Rich Lipoproteins and HDL Components in Patients With Coronary Artery Disease
Guo, X., Huang, Z., Chen, J., Hu, J., Hu, D., Peng, D., & Yu, B. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.913363 · Cited by 1
Trastornos del metabolismo lipídico
García-Díaz, J. D. D., Latorre, J. M. M., Parra, A. R. V., & Fernández, D. C. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.09.019
Godina 2015. u kardiologiji: prevencija The year in cardiology 2015: prevention
Chapman, M. J., Blankenberg, S., & Landmesser, U. (2016)
Editor-in-Chief's Picks From 2014: Part One
Fuster, V. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.12.021
Hypertriglyceridemias and Their Treatment
Real, J. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66179-2
Hypertriglyceridemia: A new paradigm
Kannampilly, J. (2018) · Journal of Diabetology · doi:10.4103/jod.jod_22_17
Dyslipidemia: Contemporary Therapy Options in Terms of Worldwide Guidelines
Djordjevic, D. B., Đorđević, A. D., & Lović, D. B. (2019) · Current Pharmacology Reports · doi:10.1007/s40495-019-00173-w
Characterisation of mineralised tissues with raman spectroscopy
You, A. Y. F. (2016) · Spiral (Imperial College London) · doi:10.25560/68024
Lecitina colesterol aciltransferasa en mujeres postmenopáusicas y su relación con factores bioquímicos y antropométricos asociados a riesgo cardiovascular
Sarmiento-Rubiano, L. A., Acosta, E. J., Rodríguez, A. S., Majana, L. S., Rebolledo-Cobos, R., & Becerra, J. E. (2019) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2019.05.004
Novel therapeutics in hypertriglyceridaemia and chylomicronaemia
García-Díaz, J. D. D. (2020) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2019.11.004
ABCA1 gene R1587K polymorphism could be associated with metabolic syndrome and increased plasma triglyceride concentration in adults from northern Mexico
Vásquez, M. N. B., Porchas-Quijada, M., Reyes-Castillo, Z., Pellegrini, O. R., Ochoa, E. A., Moya-Camarena, S. Y., & Montalvo-Corral, M. (2020) · Nutrición Hospitalaria · doi:10.20960/nh.03087
Ateroskleroz patofizyolojisinde Kruppel Benzeri Faktör 14’ün rolü
Değirmenci, U., Yıldırım, M., & Yalın, S. (2020) · Mersin üniversitesi sağlık bilimleri dergisi/Mersin üniversitesi sağlık bilimleri dergisi · doi:10.26559/mersinsbd.675368
Editor-in-Chief's Picks From 2014: Part Two
Fuster, V. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.12.022
Treinamento físico aeróbio previne a resistência insulínica e o acúmulo hepático de triglicírides em camundongos dislipidêmicos alimentados cronicamente com dieta restrita em sódio
Ferreira, G. D. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-07012022-133712
Verteilungsmuster der Atherosklerose bei peripherer arterieller Verschlusskrankheit in Abhängigkeit von vaskulären Risikofaktoren
Buser, L. (2022) · doi:10.21248/gups.67764
Features of cardiometabolic disorders in obesity on the example of the children’s population of the Rostov region
Bocharova, O. V., Teplyakova, E. D., Shkurat, T. P., Karantysh, G. V., & Ali, A. H. A. (2022) · Medical Herald of the South of Russia · doi:10.21886/2219-8075-2022-13-2-102-112
From residual risk concept to practice: History, development, evolution of the concept and current status
Gómez-López, E. A., Molina, D. I., & Castillo, J. (2023) · Revista Colombiana de Cardiología · doi:10.24875/rccar.m23000214
Effects of ethyl acetate extracts of Marsilea crenata Presl. leaves on risks of atherosclerosis in dyslipidemic rats
Susilo, J., Oktianti, D., Ashari, F. W., & Nurfahmi, A. (2023) · Jurnal kedokteran dan kesehatan Indonesia · doi:10.20885/jkki.vol14.iss3.art5
Physiopathologie des triglycérides dans l’athérosclérose : marqueurs ou acteurs du risque ?
Angoulvant, D. (2024) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2024.01.010
Triglyceride Levels Should be Lowered to Reduce Cardiovascular Risk
Corral, P., & Cobo, A. L. (2025) · doi:10.7775/rac.v93.i1.20865
Research Progress of Remnant Cholesterol in Atherosclerotic Cardiovascular Disease
王, 怡. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551354
Association of combined low-density lipoprotein cholesterol and residual cholesterol stratification with all- cause and cardiovascular mortality in peritoneal dialysis patients: a multicenter retrospective cohort studyPreprint
Chen, F., Zeng, C., Guo, H., Tian, N., Xu, Q., Zhan, X., Peng, F., Wang, X., Su, N., Feng, X., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6590878/v1
Retrospective analysis of omega-3 fatty acids and the DASH diet in hyperlipidemia and hypertension management among obese individuals
Yin, H., Zhou, Y., Zhou, Y., Ren, L., & Ma, L. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1704552
Case Report: Severe hypertriglyceridaemia and multivessel coronary artery disease – management and plaque characteristics
Kokina, B., Lapsovs, M., Roze, R., Lāce, B., Ērglis, A., & Trušinskis, K. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1622667
Additional file 1 of The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China
Huang, Q., Liu, Z., Wei, M., Huang, Q., Feng, J., Liu, Z., & Xia, J. (2023) · Figshare · doi:10.6084/m9.figshare.23250735
Additional file 1 of Lipid metabolism contribute to the pathogenesis of IgA Vasculitis
Liu, Y., Wen, M., He, Q., 党西强, Feng, S., Liu, T., Ding, X., Li, X., & He, X. (2022) · Figshare · doi:10.6084/m9.figshare.19165151
Additional file 2 of The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China
Huang, Q., Liu, Z., Wei, M., Huang, Q., Feng, J., Liu, Z., & Xia, J. (2023) · Figshare · doi:10.6084/m9.figshare.23250738
Additional file 3 of The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China
Huang, Q., Liu, Z., Wei, M., Huang, Q., Feng, J., Liu, Z., & Xia, J. (2023) · Figshare · doi:10.6084/m9.figshare.23250741
Expert consensus on the management of patients with cerebrovascular diseases and lipid metabolism disorders: focus on primary and secondary prevention
Бойцов, С. А., Владиславович, Е. М., Gurevich, V. S., Marchenkova, L. A., Sergienko, I. V., Tkacheva, O. N., Kotovskaya, Y. U. V., Mkhitaryan, E. A., Vasenina, E. E., Orlova, Y. A., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6678
Changes in apolipoproteins following ingestion of a beverage delivering β-hydroxybutyrate: results from a randomized placebo-controlled trial
Liu, Y., Kimita, W., Bharmal, S. H., & Petrov, M. S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1726174
Nonlinear associations of remnant cholesterol/high-density lipoprotein cholesterol ratio with the risk of metabolic-associated fatty liver disease: a cross-sectional study
Liu, L., Chen, D. C., Wang, S., Si, W., Zhang, H., Jiang, Y., Cai, Y., Xu, S., & Peng, X. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04739-z
The Relationship Between Triglycerides and Coronary Artery Disease Stratified by Sex and High‐Density Lipoprotein Cholesterol in Men and Women
Oe, M., Fujihara, K., Ikeda, K., Shimayama, C., Sato, T., OSAWA, T., Matsubayashi, Y., Kodama, S., Yamada, T., & Sone, H. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70156
Cerebrovascular integrity maintenance and inflammation in atherosclerosis animal models
Cataldo, V. D. (2016) · theses.fr (ABES) · doi:10.70675/7b5a6c4bz3377z40fezbf48z5da7afd1a502
Clinical Assessment of Anti-Atherogenic Function of HighDensity Lipoprotein (HDL)
Ma, F. (2018) · theses.fr (ABES) · doi:10.70675/aec01babza8edz47a2zb4d4zc7c3be00b185
Amplitude de la réponse hypertriglycéridémique postprandiale : conséquences métaboliques et contribution des microARNs
Motte, A. (2022) · theses.fr (ABES) · doi:10.70675/e0d06b04z7254z4af6z954az9551a8b58e3b
Observational associations of the residual cholesterol-to-HDL-C ratio as a metabolic correlate of low testosterone in adult men: Insights from NHANES 2011–2016
Sheng, Y., Shao, Y., Ji, N., Mei, Y., Chen, Y., Zhang, G., Liu, Y., Lu, H., Xue, D., Zhuang, Q., et al. (2026) · Medicine · doi:10.1097/md.0000000000048689
Single-Cell Analysis in Pharmacological Research for Blood Lipid Disorders
Dang, H.-L., Hoang, D.-A., & Chu, D.-T. (2026) · Springer eBooks · doi:10.1007/978-981-95-9789-5_16
Association of serum uric acid with cardiovascular risk and exploratory profiling of circulating tsRNAs in gout patients
Zhang, S., Dong, H., Liu, T., Xiao, Y., Xu, H. M., Li, H., Liang, L. Y., & Qiu, Q. (2026) · European journal of medical research · doi:10.1186/s40001-026-04791-1
Proteomic signatures characterized by inflammatory signaling and metabolic processes have divergent associations with 30-year incidence of coronary artery disease in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort
Zhou, J., Mychaleckyj, J. C., Haddad, F., Costacou, T., Orchard, T. J., & Miller, R. G. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03313-x
MIR-100-5P MODULATES POSTPRANDIAL TRIGLYCERIDE RESPONSE BY TARGETING PCSK9
VANDUYSE, A., Motte, A., Neves, C., Daclat, R., Galier, S., Bluteau, O., Materne, C., Frisdal, É., Durand, H., Giral, P., et al. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.121173
Aqueous Extract of Armillaria mellea Mushroom Exhibits Antihyperglycemic, Anti-Inflammatory and Antihyperlipidemic Activities in Streptozotocin-Induced Diabetic Rats
Kartal, D., & Özok, N. (2026) · Biology Bulletin · doi:10.1134/s1062359025613497
Hypertriglyceridemia: Causes, Consequences, Diagnosis, and Management
Qi, S., Chen, W., Chen, K., Yang, S., Wang, S., Ni, T., Xu, D., Mao, E., Chen, E., & Chen, Y. (2026) · MedComm · doi:10.1002/mco2.70956

Authors: Rosenson, R. S., Davidson, M. H., Hirsh, B. J., Kathiresan, S., & Gaudet, D.
Affiliations: Icahn School of Medicine at Mount Sinai (US)
University of Chicago (US)
Mount Sinai Hospital (US)
Harvard University (US)
Université de Montréal (CA)
Corresponding author: Rosenson, Robert S.
ORCID: Davidson, Michael H.
Hirsh, Benjamin J.
Kathiresan, Sekar
Gaudet, Daniel
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2014-12
Volume: 64
Issue: 23
Pages: 2525-2540
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2014.09.042
OpenAlex: W2005157832
Cited by: 260
References: 160
Citations by year: 2026: 16 · 2025: 25 · 2024: 12 · 2023: 26 · 2022: 27 · 2021: 21 · 2020: 28 · 2019: 23 · 2018: 21 · 2017: 19 · 2016: 26 · 2015: 15
FWCI: 3.23
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 381 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Funders: Amgen
Eli Lilly and Company
AstraZeneca
Sanofi
Regeneron Pharmaceuticals
Kowa Company
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: triglyceride-rich lipoproteins, atherosclerotic cardiovascular disease, triglycerides, genetic risk factors, causality, cardiovascular risk markers, triglyceride-lowering therapy, lipoprotein metabolism, omics, cardiovascular disease prevention
MeSH terms: Cardiovascular Diseases, Fasting, Humans, Inflammation, Intestinal Mucosa, Lipoproteins, Liver, Triglycerides, Genetic Variation, Hypertriglyceridemia, Fatty Acids, Omega-3, Sequence Analysis, DNA, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Postprandial Period, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks